Hypertensive encephalopathy, heart remodeling, and chronic heart failure
Aim. To investigate heart remodeling features and chronic heart failure (CHF) incidence in patients with hypertensive encephalopathy (HE). Material and methods. In total, 113 HE patients with Stage I-III essential arterial hypertension, as well as 26 healthy individuals (control group) were examined...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2006-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1179 |
| _version_ | 1797882817566212096 |
|---|---|
| author | L. A. Geraskina V. V. Mashin A. V. Fonyakin |
| author_facet | L. A. Geraskina V. V. Mashin A. V. Fonyakin |
| author_sort | L. A. Geraskina |
| collection | DOAJ |
| description | Aim. To investigate heart remodeling features and chronic heart failure (CHF) incidence in patients with hypertensive encephalopathy (HE). Material and methods. In total, 113 HE patients with Stage I-III essential arterial hypertension, as well as 26 healthy individuals (control group) were examined. CHF was diagnosed according to National Recommendations by Heart Failure Specialists’ Society (2002). Patients with coronary heart disease, heart valve disease, atrial fibrillation, inflammatory and toxic heart disease were excluded. Heart remodeling type, state and parameters of left ventricular (LV) contractility were assessed by echocardiography method. Results. Stage I CHF (isolated diastolic dysfunction) was diagnosed in 65 (57.5%) patients, Stage IIA CHF – in 36 (31.9%) participants. CHF was registered in majority of patients with Stage II HE (97.5%), and in all individuals with Stage III HE. Dominating heart remodeling type was concentric LV remodeling with diastolic dysfunction and normal systolic function. Neurological disturbances were associated not only with HE stage, but also with CHF presence and severity. Conclusion. In HE patients, cardiac examination and active CHF diagnostics should be stressed. Basal antihypertensive therapy in Stage II-III HE should include medications recommended for CHF treatment: ACE inhibitors, beta-blockers. |
| first_indexed | 2024-04-10T03:40:38Z |
| format | Article |
| id | doaj.art-8691e6dced6040c59a453aeafe785d64 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:40:38Z |
| publishDate | 2006-06-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-8691e6dced6040c59a453aeafe785d642023-03-13T07:23:12Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252006-06-01532227891Hypertensive encephalopathy, heart remodeling, and chronic heart failureL. A. Geraskina0V. V. Mashin1A. V. Fonyakin2НИИ неврологии РАМН. МоскваУльяновский государственный университет. УльяновскНИИ неврологии РАМН. МоскваAim. To investigate heart remodeling features and chronic heart failure (CHF) incidence in patients with hypertensive encephalopathy (HE). Material and methods. In total, 113 HE patients with Stage I-III essential arterial hypertension, as well as 26 healthy individuals (control group) were examined. CHF was diagnosed according to National Recommendations by Heart Failure Specialists’ Society (2002). Patients with coronary heart disease, heart valve disease, atrial fibrillation, inflammatory and toxic heart disease were excluded. Heart remodeling type, state and parameters of left ventricular (LV) contractility were assessed by echocardiography method. Results. Stage I CHF (isolated diastolic dysfunction) was diagnosed in 65 (57.5%) patients, Stage IIA CHF – in 36 (31.9%) participants. CHF was registered in majority of patients with Stage II HE (97.5%), and in all individuals with Stage III HE. Dominating heart remodeling type was concentric LV remodeling with diastolic dysfunction and normal systolic function. Neurological disturbances were associated not only with HE stage, but also with CHF presence and severity. Conclusion. In HE patients, cardiac examination and active CHF diagnostics should be stressed. Basal antihypertensive therapy in Stage II-III HE should include medications recommended for CHF treatment: ACE inhibitors, beta-blockers.https://cardiovascular.elpub.ru/jour/article/view/1179артериальная гипертонияэнцефалопатияхроническая сердечная недостаточность |
| spellingShingle | L. A. Geraskina V. V. Mashin A. V. Fonyakin Hypertensive encephalopathy, heart remodeling, and chronic heart failure Кардиоваскулярная терапия и профилактика артериальная гипертония энцефалопатия хроническая сердечная недостаточность |
| title | Hypertensive encephalopathy, heart remodeling, and chronic heart failure |
| title_full | Hypertensive encephalopathy, heart remodeling, and chronic heart failure |
| title_fullStr | Hypertensive encephalopathy, heart remodeling, and chronic heart failure |
| title_full_unstemmed | Hypertensive encephalopathy, heart remodeling, and chronic heart failure |
| title_short | Hypertensive encephalopathy, heart remodeling, and chronic heart failure |
| title_sort | hypertensive encephalopathy heart remodeling and chronic heart failure |
| topic | артериальная гипертония энцефалопатия хроническая сердечная недостаточность |
| url | https://cardiovascular.elpub.ru/jour/article/view/1179 |
| work_keys_str_mv | AT lageraskina hypertensiveencephalopathyheartremodelingandchronicheartfailure AT vvmashin hypertensiveencephalopathyheartremodelingandchronicheartfailure AT avfonyakin hypertensiveencephalopathyheartremodelingandchronicheartfailure |